Rare Disease Legislative Advocates in coordination with Rare Disease Congressional Caucus Co-Chairs: Representative Leonard Lance (R-NJ), Representative Joe Crowley (D-NY), Senator Orrin Hatch (R-UT), and Senator Amy Klobuchar (D-MN); and the Office of Senator Mark Kirk (R-IL) will host a briefing on:

 The NIH and FDA: Vital Agencies in the Fight Against Rare Diseases

Wednesday, May 18th, 2016

2:00 pm – 3:00 pm

Senate Capitol Visitors Center Room 201, Washington, D.C., 20004

   REGISTER   

Moderator:  Ellie Dehoney, Vice President of Policy and Advocacy, Research!America

• The Undiagnosed Disease Program at the NIH
  • William Gahl, M.D., Ph.D, Clinical Director, National Human Genome Research Institute (invited)
• Precision Medicine – The White House & the NIH
  • Matthew Might, Strategist, Executive Office of the President, The White House, Associate Professor, University of Utah, Associate Professor, Visiting, Harvard Medical School, Founder, NGLY1.org (invited)
• The Value of Patients to Clinical Innovation at the NIH
  • Kayla Martinez & Dorelia Rivera, NOMID Patient
• The Role of NIH Funding in Kickstarting Biomedical Innovation
  • Christopher C. Gibson, Ph.D, Co-Founder & CEO, Recursion Pharmaceuticals

Come and enjoy an array of refreshments  or have coffee and snack break while learning about the role of our health agencies.